Holy Spirit Hospital and Research Centre Introduces Next-Generation Tomotherapy Radixact X9 with C-RAD SGRT for Advanced Precision Radiation Therapy

Mumbai, September 2026:

Holy Spirit Hospital and Research Centre has taken a significant step forward in cancer care with the commissioning and commencement of clinical services on the Accuray Tomotherapy Radixact X9, integrated with C-RAD Surface Guided Radiation Therapy (SGRT)—bringing next-generation precision radiation therapy technology to patients in Mumbai.

The Radixact X9 is an advanced helical radiation therapy platform designed to deliver highly precise and conformal radiation while treating complex tumour sites. Its ability to deliver IMRT/IGRT and adaptive radiation therapy approaches, along with advanced image guidance and motion-management capabilities, enables clinicians to tailor treatment more accurately to individual patients.

A particularly important addition is C-RAD SGRT, which provides real-time, non-invasive monitoring of the patient’s external surface and movement during radiation treatment. It can assist with patient positioning, motion monitoring and breath-hold techniques such as Deep Inspiration Breath Hold (DIBH), which is particularly valuable in selected breast and thoracic cancers where reducing radiation exposure to the heart and lungs is an important treatment objective.

A First-of-its-Kind Initiative in Mumbai

The integration of C-RAD SGRT with the Tomotherapy Radixact X9 at Holy Spirit Hospital and Research Centre represents a first-of-its-kind installation in Mumbai, bringing together advanced image-guided radiation therapy and real-time surface guidance within a comprehensive cancer-care environment.

For patients, the significance of this technology goes beyond the sophistication of the machine. Modern radiation oncology is increasingly focused on precision, safety, reproducibility and personalization of treatment. Technologies such as Radixact and SGRT can help radiation oncologists deliver highly targeted treatment while improving patient positioning and monitoring throughout the treatment process.

Dr. Ajay Kolse, Consultant Radiation Oncologist, Holy Spirit Hospital and Research Centre, said:

“The introduction of the Radixact X9 with C-RAD SGRT marks an important milestone in our commitment to bringing advanced radiation therapy closer to our patients. While technology provides us with increasingly sophisticated tools, our ultimate goal remains simple—to deliver the right treatment, with greater precision and safety, while keeping the individual needs and well-being of every patient at the centre of care.”

The new facility further strengthens Holy Spirit Hospital and Research Centre’s vision of providing comprehensive cancer care under one roof, with multidisciplinary collaboration between Radiation Oncology, Medical Oncology, Surgical Oncology, Hematology and Palliative Care teams.

The hospital management expressed its commitment to investing in advanced technology and infrastructure to ensure that patients have access to contemporary cancer treatment within Mumbai.

Ultimately, the true measure of advanced technology is not how sophisticated it is, but how meaningfully it improves the care and lives of our patients. At Holy Spirit Hospital and Research Centre, technology will continue to evolve and treatment techniques will continue to advance—but the commitment to compassionate care and providing every patient with the best possible treatment will remain constant.